Jun 20, 2026
14 MIN READ

Ozempic Shortage: What to Do and Where to Turn

Ozempic supply constraints have left many patients without access to this critical GLP-1 medication. PlexusDx provides a practical alternative through compounded semaglutide injections, delivering the same active ingredient from licensed 503A pharmacies at transparent, affordable pricing.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 20, 2026
14 MIN READ

ozempic shortage: what to do and where to turn — PlexusDx GLP-1 education

Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic scarcity has affected millions of patients seeking glucagon-like peptide-1 (GLP-1) therapy for weight loss and metabolic health. Manufacturing delays and increased demand have created significant gaps in medication availability across the United States. PlexusDx addresses this access barrier by delivering compounded semaglutide injection from licensed 503A compounding pharmacies, ensuring patients can continue their weight loss journey without interruption.

Understanding the Current Ozempic Supply Challenge

Ozempic shortages began in 2022 when demand for semaglutide surged beyond manufacturer Novo Nordisk's production capacity. The FDA reported periodic supply constraints throughout 2023 and into 2024, creating unpredictable access for patients already stabilized on the medication. Pharmacy wait times extended to weeks or months, forcing many individuals to pause treatment or explore alternative sources.

The shortage has disproportionately affected patients relying on brand-name Ozempic through traditional insurance channels. Those with inconsistent pharmacy inventory faced dose interruptions, which can reduce treatment effectiveness and trigger unwanted weight regain. This supply instability highlighted a critical gap in the U.S. healthcare system's ability to meet legitimate patient demand for evidence-based weight loss therapy.

Why Compounded Semaglutide Offers a Reliable Alternative

Compounded semaglutide contains the identical active pharmaceutical ingredient as brand-name Ozempic, manufactured under strict quality standards by licensed 503A compounding pharmacies. These facilities operate under federal oversight and state pharmacy board regulations, ensuring potency, sterility, and purity equivalent to mass-manufactured versions. Compounding allows pharmacies to produce consistent supply without dependence on a single manufacturer's production timeline.

PlexusDx partners exclusively with licensed 503A compounding pharmacies to deliver semaglutide injections to all 50 states. Patients access the same therapeutic outcomes as brand-name Ozempic while avoiding months-long wait lists. The compounded formulation is delivered directly to patients' homes, eliminating trips to traditional pharmacies and enabling flexible, continuous treatment cycles.

Affordability and Access Without Insurance Requirements

PlexusDx semaglutide injection pricing starts at $149 per month across three commitment tiers, with your dose able to increase while your monthly price remains stable. This transparent pricing model eliminates surprise costs and the insurance approval delays that often extend Ozempic shortages for covered patients. No insurance is required, and HSA and FSA accounts are eligible for payment, lowering out-of-pocket costs for eligible individuals.

Patients previously trapped in insurance networks can now access treatment directly, regardless of formulary restrictions or prior authorization denials. The flat monthly rate removes the financial unpredictability that discourages consistent weight loss treatment. PlexusDx serves patients across all 50 states, ensuring geographic location no longer determines medication access.

Choosing the Right Semaglutide Format for Your Needs

PlexusDx offers both compounded semaglutide injection and oral semaglutide, allowing patients to select the delivery method matching their preferences and clinical response. Injection formulations typically achieve higher bioavailability and more predictable dose escalation, making them ideal for patients requiring rapid therapeutic effect or those with absorption concerns. Oral semaglutide provides convenience for needle-averse patients, though it requires strict administration timing on an empty stomach.

Genetic factors influence individual response to semaglutide, including variations in GLP-1 receptor sensitivity and metabolic pathway efficiency. PlexusDx Precision Peptide Genetic Test identifies your genetic predispositions across 14 metabolic pathways, informing whether injection or oral delivery and which compound concentration may optimize your results. This personalized approach accelerates finding your effective dose while minimizing trial-and-error delays.

Getting Started During Medication Supply Uncertainty

Patients currently facing Ozempic delays can initiate PlexusDx semaglutide therapy immediately through a straightforward online consultation process. Your personal healthcare team reviews your medical history, current medications, and weight loss goals to establish a safe starting dose. Most patients receive their first shipment within 5-7 business days, allowing uninterrupted continuity of care.

If you're already on brand-name Ozempic, switching to PlexusDx compounded semaglutide requires no restart period—your effective dose transfers directly to the new formulation. This seamless transition prevents the dose-adjustment delays that accompany traditional medication changes. PlexusDx eliminates the gap between supply shortage and treatment resumption that leaves patients vulnerable to relapse.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as effective as brand-name Ozempic?

Yes. Compounded semaglutide contains the identical active ingredient as Ozempic and is manufactured by licensed 503A compounding pharmacies under federal quality standards. Clinical outcomes are equivalent when dosing and injection technique remain consistent. The primary difference is supply reliability and pricing transparency, not therapeutic effectiveness.

How quickly can I start PlexusDx semaglutide if my Ozempic supply ran out?

PlexusDx patients typically receive their first semaglutide shipment within 5-7 business days of completing their online consultation. If you're already on an established Ozempic dose, you can transfer directly to the same strength compounded semaglutide without a restart period, maintaining your treatment momentum.

Will my price increase as my semaglutide dose goes higher?

No. PlexusDx semaglutide injection pricing remains flat at $149/month minimum across all dose levels and commitment tiers. Your dose may need to go up during titration, but your monthly price won't change—eliminating cost surprises as you optimize your therapy.

Can I use HSA or FSA funds to pay for PlexusDx semaglutide?

Yes. PlexusDx semaglutide injections are eligible for HSA and FSA account payments, reducing your out-of-pocket expenses through pre-tax healthcare funds. Patients without insurance can pay directly, and no membership fees apply regardless of payment method.

What is the Precision Peptide Genetic Test, and how does it help with semaglutide therapy?

The Precision Peptide Genetic Test ($99 add-on after your first treatment month) analyzes 14 metabolic pathways and 150+ genetic insights, including GLP-1 receptor sensitivity variants (rs6923761) and related peptide-pathway genes. These results inform whether injection versus oral semaglutide, specific dose ranges, and complementary compounds may optimize your individual weight loss response based on your genetic predispositions.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves